This event was previously submitted on a summary report (e2013038b).
subsequently, medtronic has received additional information which is being submitted via this 3500a.
Exemption number: (b)(4).
If information is provided in the future, a supplemental report will be issued.
|
The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of pelvic organ prolapse, urinary incontinence.
It was reported that after implant, the patient experienced blood loss, pain, discomfort, erosion, infection, fistulae, scarring, cystocele, enterocele(prolapse), rejected vaginal graft, unspecified mesh complications, unspecified urinary problems, unspecified bowel problems, recurrence, dyspareunia, unspecified neuromuscular problems, postgraft pain, fibrotic nodule in segment of graft, graft with necrotic material, paravaginal defect, mass effect, banding, and required nonsurgical and additional surgical interventions.
The device had been used with tension-free vaginal tape ethicon/ johnson + johnson.
|